191 related articles for article (PubMed ID: 30406350)
1. Platelet number and graft function predict intensive care survival in allogeneic stem cell transplantation patients.
Turki AT; Lamm W; Schmitt C; Bayraktar E; Alashkar F; Metzenmacher M; Wohlfarth P; Beelen DW; Liebregts T
Ann Hematol; 2019 Feb; 98(2):491-500. PubMed ID: 30406350
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic stem cell transplantation recipients requiring intensive care: time is of the essence.
Orvain C; Beloncle F; Hamel JF; Del Galy AS; Thépot S; Mercier M; Kouatchet A; Farhi J; Francois S; Ifrah N; Mercat A; Asfar P; Hunault-Berger M; Tanguy-Schmidt A
Ann Hematol; 2018 Sep; 97(9):1601-1609. PubMed ID: 29717367
[TBL] [Abstract][Full Text] [Related]
3. Absolute lymphocyte count recovery after allogeneic hematopoietic stem cell transplantation predicts clinical outcome.
Kim HT; Armand P; Frederick D; Andler E; Cutler C; Koreth J; Alyea EP; Antin JH; Soiffer RJ; Ritz J; Ho VT
Biol Blood Marrow Transplant; 2015 May; 21(5):873-80. PubMed ID: 25623931
[TBL] [Abstract][Full Text] [Related]
4. Different Impact of the Number of Organ Failures and Graft-Versus-Host Disease on the Outcome of Allogeneic Stem Cell Transplantation Recipients Requiring Intensive Care.
Orvain C; Beloncle F; Hamel JF; Thépot S; Mercier M; Kouatchet A; Farhi J; Francois S; Guardiola P; Asfar P; Hunault-Berger M; Mercat A; Ifrah N; Tanguy-Schmidt A
Transplantation; 2017 Feb; 101(2):437-444. PubMed ID: 26950729
[TBL] [Abstract][Full Text] [Related]
5. Admission of hematopoietic cell transplantation patients to the intensive care unit at the Pontificia Universidad Católica de Chile Hospital.
Escobar K; Rojas P; Ernst D; Bertin P; Nervi B; Jara V; Garcia MJ; Ocqueteau M; Sarmiento M; Ramirez P
Biol Blood Marrow Transplant; 2015 Jan; 21(1):176-9. PubMed ID: 25139214
[TBL] [Abstract][Full Text] [Related]
6. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports.
Pène F; Aubron C; Azoulay E; Blot F; Thiéry G; Raynard B; Schlemmer B; Nitenberg G; Buzyn A; Arnaud P; Socié G; Mira JP
J Clin Oncol; 2006 Feb; 24(4):643-9. PubMed ID: 16380411
[TBL] [Abstract][Full Text] [Related]
7. Improved Treatment-Related Mortality and Overall Survival of Patients with Grade IV Acute GVHD in the Modern Years.
El-Jawahri A; Li S; Antin JH; Spitzer TR; Armand PA; Koreth J; Nikiforow S; Ballen KK; Ho VT; Alyea EP; Dey BR; McAfee SL; Glotzbecker BE; Soiffer RJ; Cutler CS; Chen YB
Biol Blood Marrow Transplant; 2016 May; 22(5):910-8. PubMed ID: 26748160
[TBL] [Abstract][Full Text] [Related]
8. Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients.
Lengliné E; Chevret S; Moreau AS; Pène F; Blot F; Bourhis JH; Buzyn A; Schlemmer B; Socié G; Azoulay E
Bone Marrow Transplant; 2015 Jun; 50(6):840-5. PubMed ID: 25798675
[TBL] [Abstract][Full Text] [Related]
9. Outcomes and Long-Term Survival of Adolescent and Young Adult Patients Admitted to the Intensive Care Unit Following Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience of 152 Patients.
Solaiman OM; Elhassan T; Fakih RE; Mannan A; Alduhailib Z; Mahdali AA; Alzahrani H; Jamil M; Chaudhri N; Elhazmi A; Kolko M; Al-Sharif FZ; Alrbiaan A; Shaban M; Shaheen M; Salahuddin N; Alfraih FA; Altarifi AS; Hassanein M; Hosaini S; Alhashim N; Mohamed AA; Hanbali A; Aljanoubi AH; Al-Obaidi NR; Rasheed W; Maghrabi K; Almohareb F; Soubani A; Aljurf M; Ahmed SO
Hematol Oncol Stem Cell Ther; 2024 Mar; 17(2):110-119. PubMed ID: 38560973
[TBL] [Abstract][Full Text] [Related]
10. Survival and Late Effects after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancy at Less than Three Years of Age.
Vrooman LM; Millard HR; Brazauskas R; Majhail NS; Battiwalla M; Flowers ME; Savani BN; Akpek G; Aljurf M; Bajwa R; Baker KS; Beitinjaneh A; Bitan M; Buchbinder D; Chow E; Dandoy C; Dietz AC; Diller L; Gale RP; Hashmi SK; Hayashi RJ; Hematti P; Kamble RT; Kasow KA; Kletzel M; Lazarus HM; Malone AK; Marks DI; O'Brien TA; Olsson RF; Ringden O; Seo S; Steinberg A; Yu LC; Warwick A; Shaw B; Duncan C
Biol Blood Marrow Transplant; 2017 Aug; 23(8):1327-1334. PubMed ID: 28461213
[TBL] [Abstract][Full Text] [Related]
11. Comparison of outcomes after two standards-of-care reduced-intensity conditioning regimens and two different graft sources for allogeneic stem cell transplantation in adults with hematologic diseases: a single-center analysis.
Le Bourgeois A; Mohr C; Guillaume T; Delaunay J; Malard F; Loirat M; Peterlin P; Blin N; Dubruille V; Mahe B; Gastinne T; Le Gouill S; Moreau P; Mohty M; Planche L; Lode L; Bene MC; Chevallier P
Biol Blood Marrow Transplant; 2013 Jun; 19(6):934-9. PubMed ID: 23523970
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors and Impact of Secondary Failure of Platelet Recovery After Allogeneic Stem Cell Transplantation.
Akahoshi Y; Kanda J; Gomyo A; Hayakawa J; Komiya Y; Harada N; Kameda K; Ugai T; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kimura SI; Kikuchi M; Nakasone H; Kako S; Kanda Y
Biol Blood Marrow Transplant; 2016 Sep; 22(9):1678-1683. PubMed ID: 27288954
[TBL] [Abstract][Full Text] [Related]
13. Double reduced-intensity allogeneic hematopoietic stem cell transplantation: a retrospective study from the SFGM-TC.
Bay JO; Cabrespine A; Faucher C; Tabrizi R; Bordigoni P; Berceanu A; Coiteux V; Renaud M; Mialou V; Robin M; Kuentz M; Chevallier P; Dhédin N; Huynh A; Garban F; Witz F; Buzyn A; De Revel T; Galambrun C; Deconinck E; Contentin N; François S; Gratecos N; Blaise D; Michallet M;
Biol Blood Marrow Transplant; 2012 Feb; 18(2):250-6. PubMed ID: 21745455
[TBL] [Abstract][Full Text] [Related]
14. A study of a reduced-intensity conditioning regimen followed by allogeneic stem cell transplantation for patients with hematologic malignancies using Campath-1H as part of a graft-versus-host disease strategy.
Shore T; Harpel J; Schuster MW; Roboz GJ; Leonard JP; Coleman M; Feldman EJ; Silver RT
Biol Blood Marrow Transplant; 2006 Aug; 12(8):868-75. PubMed ID: 16864057
[TBL] [Abstract][Full Text] [Related]
15. Quantitation of hematogones at the time of engraftment is a useful prognostic indicator in allogeneic hematopoietic stem cell transplantation.
Shima T; Miyamoto T; Kikushige Y; Mori Y; Kamezaki K; Takase K; Henzan H; Numata A; Ito Y; Takenaka K; Iwasaki H; Kamimura T; Eto T; Nagafuji K; Teshima T; Kato K; Akashi K
Blood; 2013 Jan; 121(5):840-8. PubMed ID: 23233661
[TBL] [Abstract][Full Text] [Related]
16. CD34(+)-selected stem cell boost without further conditioning for poor graft function after allogeneic stem cell transplantation in patients with hematological malignancies.
Klyuchnikov E; El-Cheikh J; Sputtek A; Lioznov M; Calmels B; Furst S; Chabannon C; Crocchiolo R; Lemarié C; Faucher C; Bacher U; Alchalby H; Stübig T; Wolschke C; Ayuk F; Reckhaus ML; Blaise D; Kröger N
Biol Blood Marrow Transplant; 2014 Mar; 20(3):382-6. PubMed ID: 24321747
[TBL] [Abstract][Full Text] [Related]
17. A reappraisal of ICU and long-term outcome of allogeneic hematopoietic stem cell transplantation patients and reassessment of prognosis factors: results of a 5-year cohort study (2009-2013).
Platon L; Amigues L; Ceballos P; Fegueux N; Daubin D; Besnard N; Larcher R; Landreau L; Agostini C; Machado S; Jonquet O; Klouche K
Bone Marrow Transplant; 2016 Feb; 51(2):256-61. PubMed ID: 26569092
[TBL] [Abstract][Full Text] [Related]
18. Serum albumin level predicts survival of patients with gastrointestinal acute graft-versus-host disease after allogeneic stem cell transplantation.
Ayuk F; Bussmann L; Zabelina T; Veit R; Alchalby H; Wolschke C; Lellek H; Bacher U; Zander AR; Kröger N
Ann Hematol; 2014 May; 93(5):855-61. PubMed ID: 24248672
[TBL] [Abstract][Full Text] [Related]
19. Improved short- and long-term outcome of allogeneic stem cell recipients admitted to the intensive care unit: a retrospective longitudinal analysis of 942 patients.
Lueck C; Stadler M; Koenecke C; Hoeper MM; Dammann E; Schneider A; Kielstein JT; Ganser A; Eder M; Beutel G
Intensive Care Med; 2018 Sep; 44(9):1483-1492. PubMed ID: 30141173
[TBL] [Abstract][Full Text] [Related]
20. Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort on Behalf of the Grupo Español de Trasplante Hematopoyetico.
Orti G; Sanz J; Bermudez A; Caballero D; Martinez C; Sierra J; Cabrera Marin JR; Espigado I; Solano C; Ferrà C; García-Noblejas A; Jimenez S; Sampol A; Yañez L; García-Gutiérrez V; Pascual MJ; Jurado M; Moraleda JM; Valcarcel D; Sanz MA; Carreras E; Duarte RF
Biol Blood Marrow Transplant; 2016 Mar; 22(3):584-8. PubMed ID: 26631751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
